Transcatheter patent ductus arteriosus closure in an infant using the Gianturco-Grifka Vascular Occlusion Device.
A 2-month-old child with Down syndrome and a large patent ductus arteriosus underwent transcatheter closure using a new Food and Drug Administration-approved occlusion device. This device is described, along with its usefulness for other vascular defects.
Grifka
R G
RG
Lillie Frank Abercrombie Section of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Vincent
J A
JA
Nihill
M R
MR
Ing
F F
FF
Mullins
C E
CE
D006328:Cardiac Catheterization / Q000295:instrumentation*; D004374:Ductus Arteriosus, Patent / Q000628:therapy*; D004867:Equipment Design; D006801:Humans; D007223:Infant